Samar El Achy
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Gene expression and cancer classification 1
- Surgery 4
- Bladder and Urothelial Cancer Treatments 3
- Co-authors
- Tamer Refaat (7 shared papers)M. Houri (2 shared papers)Remon Bazak (2 shared papers)Wael K.A. Hussein (1 shared paper)Mennatallah A. Gowayed (5 shared papers)Wessam M. El-Refaie (1 shared paper)Kristiina M. Huttunen (1 shared paper)Samar O. El-Ganainy (1 shared paper)
- Journals
- International Journal of Pharmaceutics (2 papers)Journal of Drug Delivery Science and Technology (2 papers)BMC Cancer (2 papers)Life Sciences (2 papers)Journal of Cancer Research and Clinical Oncology (1 paper)
- Partner nations
- EgyptUnited StatesSaudi Arabia
In The Last Decade
Samar El Achy
28 papers receiving 1.1k citations
Samar El Achy's Hit Papers
Peers
Comparison fields: 5 of 97
- Biomaterials 497
- Biomedical Engineering 450
- Molecular Medicine 41
- Pharmaceutical Science 51
- Molecular Biology 405
Countries citing papers authored by Samar El Achy
This map shows the geographic impact of Samar El Achy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar El Achy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar El Achy more than expected).
Fields of papers citing papers by Samar El Achy
This network shows the impact of papers produced by Samar El Achy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar El Achy. The network helps show where Samar El Achy may publish in the future.
Co-authors
The 25 scholars most cited alongside Samar El Achy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer active targeting by nanoparticles: a comprehensive review of literature Hit paper breakdown → | 2014 | 561 |
| 2 | 2014 | 295 | |
| 3 | 2021 | 43 | |
| 4 | 2015 | 26 | |
| 5 | 2022 | 17 | |
| 6 | 2021 | 17 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 13 | |
| 9 | 2021 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2016 | 10 | |
| 12 | 2022 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2018 | 8 | |
| 15 | 2016 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2019 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2019 | 4 | |
| 20 | 2024 | 4 |
About Samar El Achy
Samar El Achy is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Epidemiology and Biomaterials, having authored 32 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Endometrial and Cervical Cancer Treatments (2 papers), Advanced Drug Delivery Systems (2 papers), Multiple Sclerosis Research Studies (2 papers), Curcumin's Biomedical Applications (2 papers), Radiation Therapy and Dosimetry (1 paper) and Gene expression and cancer classification (1 paper). The work is most often cited by research in Biomaterials (497 citations), Biomedical Engineering (450 citations), Molecular Medicine (41 citations), Pharmaceutical Science (51 citations) and Molecular Biology (405 citations). Samar El Achy has collaborated with scholars based in Egypt, United States and Saudi Arabia. Frequent co-authors include Tamer Refaat, M. Houri, Remon Bazak, Wael K.A. Hussein, Mennatallah A. Gowayed, Wessam M. El-Refaie, Kristiina M. Huttunen, Samar O. El-Ganainy, Ossama Y. Abdallah and Marwa M. Essawy. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Drug Delivery Science and Technology, BMC Cancer, Life Sciences and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.